Chemical pathology V - Plasma lipid and lipoprotein Flashcards

1
Q

6 plasma lipiprotein calsses?

A
HDL
LDL
IDL 
VLDL
Chylomicrons 
Lipoprotein A (LDL variant, pathogenic)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Content and apolipoproteins in HDL?

A

Cholesteyl ester

A-I,A-II, C,E

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Content and apolipoproteins in LDL?

A

CE

B-100

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Content and apolipoproteins in IDL?

A

CE + TG

B-100, C, E

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Content and apolipoproteins in VLDL?

A

TG (liver)

B-100, C, E

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Content and apolipoproteins in Chylomicron?

A

TG (intestine)

B-48, C, E, A-I, A-II, A-IV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Content and apolipoproteins in Lipoprotein A?

A

CE
B-100
Lipoprotein A

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Morphological classification of serum lipid disorders?

A

Fredrickson classification

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Frederickson phenotype: Type I
Clear or turbid?
Lipoprotein abnormality?
Associated disorders?

A

Creamy top layer

Chylomicron

Lipoprotein lipase deficiency, apolipoprotein C-II deficiency

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Frederickson phenotype: Type IIa
Clear or turbid?
Lipoprotein abnormality?
Associated disorders?

A

Clear

LDL

Familial hypercholesterolemia, polygenic hypercholesterolemia, nephrosis, hypothyroidism, familial combined hyperlipidemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Frederickson phenotype: Type IIb
Clear or turbid?
Lipoprotein abnormality?
Associated disorders?

A

Clear

LDL, VLDL

Familial combined hyperlipidemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Frederickson phenotype: Type III
Clear or turbid?
Lipoprotein abnormality?
Associated disorders?

A

Turbid

IDL

Dysbetalipoproteinemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Frederickson phenotype: Type IV
Clear or turbid?
Lipoprotein abnormality?
Associated disorders?

A

Turbid

VLDL

Familial hypertriglyceridemia, familial combined hyperlipidemia, sporadic hypertriglyceridemia, diabetes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Frederickson phenotype: Type V
Clear or turbid?
Lipoprotein abnormality?
Associated disorders?

A

Creamy top, turbid bottom

Chylomicrons, VLDL

Diabetes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Patient:

  • 2/m
  • Healthy
  • Achilles Xanthoma, elbow xanthoma, bilateral
  • No family history, except maternal grandmother stroke from hyperlipidemia
  • High LDL, High total cholesterol, Clear serum

Dx?

A

Clear serum: type IIa or IIb
Most often type IIa

Familial hypercholesterolemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Treatment of Familial combined hyperlipidemia

A

Low cholesterol diet

Cholestyramine

17
Q

Which phenotypes in Fredrickson classification of hyperlipidemia have high atherogenicity?

A

Major: IIa, IIb, III

Minor: IV, V

Not atherogenicity: I

18
Q

Which phenotype in Fredrickson classification of hyperlipidemia has normal Plasma TG level?

A

IIa

Only one**

19
Q

3 mutations that cause familial hypercholestrolemia?

A

LDLR gene mutation *** (90%)
APOB (Apolipoprotein B) (10%)
PCSK9 (gain of function) (<5%)

20
Q

3 mutations for autosomal recessive hypercholesterolemia

A

1) LDLR-AP1 reduced expression
2) ABCG5, ABCG8 deficiency > Sitosterolemia
3) CYP7A1 deficiency (decrease bile acid synthesis, high intrahepatic cholesterol)

21
Q

3 main causes of inherited high cholesterol

A

Familial hypercholestrolemia
Familial combined hyperlipidemia
Cerebrotendinous xanthomatosis

22
Q

D/dx cerebrotendinous xanthomatosis with familial hypercholestrolemia causing xanthoma formation

A

Both cause xanthoma

Cerebrotendinous xanthomatosis affects cognitive function, cause paraplegia and dementia, but NOT hypercholestrolemia

23
Q

4 criteria for clinical Dx of Familial hypercholestrolemia

A

1) Positive family history + high LDL
2) Tendon xanthoma + high LDL
3) Very high LDL (>6.2, under 20 years old)
4) DNA test for mutation (85% accurate only, not gold standard)

24
Q

Patient with familial hypercholesterolemia
2 heterozygous mutations in LDLR gene
- One missense (in mother)
- One duplication error (not found in parents)

2 possible cause of duplication error?

A

Germline mosaicism in one parent

De novo mutation

25
What factors affect the phenotype of heterozygous familial hypercholestrolemia? What factors affect the phenotype of homozygous familial hypercholestrolemia?
Heterozygous: phenotype increase by Western lifestyle and diet: > 90% penetrance of LDLR with markedly high LDL All homozygous = severely affected
26
Common complication of homozygous familial hypercholesterolemia?
Sever coronary heart disease Onset at mid-20s
27
Treatment of heterozygous and homozygous familial hypercholesterolemia?
Heterozygous: Statin + Bile acid-binding resin drugs Homozygous: - LDL apheresis to reduce plasma LDL every 1-4 weeks ****1st line, preferred**** - Liver transplant to replace defective hepatic LDLR before coronary heart disease
28
Describe transport of cholesteryl ester in LDL into cells? Defective transport consequence?
CE in LDL is shielded by hydrophilic coating (phospholipid, apoB-100, Unesterified cholesterol) Receptor - mediated endocytosis of LDL by LDLR takes CE into cells Defective LDLR on liver cells = accumulation of LDL in plasma
29
MoA of HMG- COA reductase inhibitor and bile acid-binding resin?
Bile acid binding resin = stop enterohepatic recycling of bile acid = more excretion of cholesterol into intestines + More LDL intake in hepatocytes to form bile acid (upregulate LDLR) HMG-CoA reductase inhibitor = stop production of cholesterol in liver = Upregulation of LDLR to uptake plasma LDL to make bile acid for excretion through intestines
30
4 components of blood phytosterol profile test
Cholestanol Campesterol Stigmasterol Beta-stiosterol
31
Sitosterolemia. - Mutation - Effect on metabolism of plant sterols? - Disease?
ATP-Binding-Cassette: ABC-G5, ABC-G8 mutation Increase GI absorption and decrease biliary excretion of plant sterols autosomal recessive hypercholesterolemia
32
Clinical presentation of sitosterolemia?
``` Xanthoma Premature atherosclerosis Hemolytic anemia Large platelets Increase plasma concentration of plant sterols: sitosterol, campesterol, stigmasterol ```
33
Treatment of Sitosterolemia? | Genetic counselling of family?
Low plant sterol diet Ezetimibe: inhibit cholesterol and plant sterol uptake by NPC1L1 transporter No response to statin Offsprings are obligate carrier: plasma conc. of plant sterols is normal in carrier
34
3 d/dx of xanthoma formation
Familial hypercholestrolemia Sitosterolemia Cerebrotendinous xanthomatosis
35
``` Patient: 50/M Chronic achilles tendon xanthoma Serum clear High Campesterol (10x) ``` Dx?
Sitosterolemia autosomal recessive hypercholesterolemia ABCG5 and ABCG8 mutations Increase GI absorption and decrease biliary excretion of plant sterols
36
``` Patient: 58/M Spastic tetraparesis unknown cause Wheelchair bound Achilles xanthoma Clear serum with normal lipid profile, high Cholestanol (3X) ``` Dx?
Cerebrotendinous xanthomatosis Autosomal recessive lipid storage disease
37
Cerebrotendinous xanthomatosis - Inheritance pattern, mutation? - Effect of mutation? - Clinical manifestation (5)
Autosomal recessive lipid storage disease: CYP27A1 mutation Cholesterol cannot be converted into bile acid >> convert to cholestenol and bile alcohol - Tendon xanthoma - Progressive neurologic dysfunction (dementia, cerebellar, seizures...etc) - Chronic diarrhea - premature cataract - Early onset osteoporosis
38
Treatment for cerebretendinous xanthomatosis?
Bile acid replacement therapy (chenodeoxycholic acid, Ursodeoxycholic acid) >> restart bile acid negative feedback mechanism